CEO Seth Blackley was paid $14,240,154 in fiscal year 2025, ↑ up 27.9% from fiscal year 2024, the 88th percentile of its disclosed peer group (SEC filing 0001193125-26-177267 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
$14,240,154 ↑ Seth Blackley total, FY2025 | 88th CEO pay percentile vs peers | 192.6:1 CEO-to-median pay ratio | 88.05% Say-on-pay support, latest vote |
Track this company's pay every filing: join the Pro seat waitlist
Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year
Ask our research desk — $99, 24h, every figure cited to its filing.
EVH's next annual pay disclosure, estimated April 23, 2027.est. Filing ↗
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Seth Blackley | $867,068 | $660,000 | $12,699,086 | $0 | $0 | $0 | $0 | $14,240,154 |
| Chief Executive Officer | ||||||||
| Daniel McCarthy | 650,301 | 495,000 | 8,466,063 | 0 | 0 | 0 | 11,915 | 9,623,279 |
| President | ||||||||
| John Johnson | 541,918 | 0 | 4,815,032 | 0 | 0 | 0 | 13,721 | 5,370,671 |
| Former Chief Financial Officer; Chief Strategy Officer | ||||||||
| Jonathan Weinberg | 460,360 | 262,969 | 1,902,335 | 0 | 0 | 0 | 14,000 | 2,639,664 |
| General Counsel | ||||||||
| Emily Rafferty | 454,342 | 277,171 | 1,659,331 | 0 | 0 | 0 | 13,781 | 2,404,625 |
| Former Chief Operating Officer; EVP, Customer Success | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Seth Blackley | $14,240,154 | $11,136,185 | $8,931,188 | ↑ +3,103,969 |
| Daniel McCarthy | 9,623,279 | 7,484,923 | 5,763,625 | ↑ +2,138,356 |
| John Johnson | 5,370,671 | 4,814,291 | 3,530,596 | ↑ +556,380 |
| Jonathan Weinberg | 2,639,664 | 1,966,449 | 2,012,894 | ↑ +673,215 |
| Emily Rafferty | 2,404,625 | 2,009,212 | 2,291,560 | ↑ +395,413 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
You have just read Evolent Health's Summary Compensation Table. The whole free brief as a PDF, emailed now, with every figure cited — then a few short notes on the deeper EVH reports.
We send the PDF right away, then up to three short notes. Reply “unsubscribe” to any of them, any time.
How we handle your data → Privacy
Each company listed discloses EVH in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named EVH in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
One page per director: the seat, the committees and the fee table, read for one person at a time.
| Director | Role | FY2025 total |
|---|---|---|
| Brendan Springstubb | Independent Director | $373,417 |
| Cheryl Scott | Former director (through FY2025) | $282,500 |
| Craig Barbarosh | Independent Director | $282,500 |
| Diane Holder | Independent Director | — |
| Jill Smith | Independent Director | — |
| Kim Keck | Independent Director | $292,500 |
| M. Bridget Duffy, MD | Former director (through FY2025) | — |
| Peter Grua | Independent Director | $280,000 |
| Richard Jelinek | Chair of the Board | $425,000 |
| Russell Glass | Independent Director | $275,000 |
| Shawn Guertin | Independent Director | $270,000 |
| Toyin Ajayi, MD | Independent Director | $282,500 |
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Craig Barbarosh | Director | 2026-06-04 | A | 41,096 | $0 | $0 | Common | Form 4 ↗ |
| Brendan Springstubb | Director | 2026-06-04 | A | 41,096 | 0 | 0 | Common | Form 4 ↗ |
| Jill Smith | Director | 2026-06-04 | A | 41,096 | 0 | 0 | Common | Form 4 ↗ |
| Kim Keck | Director | 2026-06-04 | A | 41,096 | 0 | 0 | Common | Form 4 ↗ |
| Richard Jelinek | Director | 2026-06-04 | A | 41,096 | 0 | 0 | Common | Form 4 ↗ |
| Shawn Guertin | Director | 2026-06-04 | A | 41,096 | 0 | 0 | Common | Form 4 ↗ |
| Peter Grua | Director | 2026-06-04 | A | 41,096 | 0 | 0 | Common | Form 4 ↗ |
| Russell Glass | Director | 2026-06-04 | A | 41,096 | 0 | 0 | Common | Form 4 ↗ |
| Toyin Ajayi, MD | Director | 2026-06-04 | A | 41,096 | 0 | 0 | Common | Form 4 ↗ |
| Aammaad Shams | Chief Accounting Officer | 2026-07-01 | A | 28,790 | 0 | 0 | Common | Form 4 ↗ |
| Daniel McCarthy | PRESIDENT | 2026-07-01 | D | 4,582 | 6 | 26,301 | Common | Form 4 ↗ |
| Jonathan Weinberg | General Counsel | 2026-07-01 | D | 2,650 | 6 | 15,211 | Common | Form 4 ↗ |
| Seth Blackley | Director | 2026-07-01 | D | 10,297 | 6 | 59,105 | Common | Form 4 ↗ |
| Daniel McCarthy | PRESIDENT | 2026-07-01 | A | 302,585 | 0 | 0 | Common | Form 4 ↗ |
| Jonathan Weinberg | General Counsel | 2026-07-01 | A | 43,055 | 0 | 0 | Common | Form 4 ↗ |
| Seth Blackley | Director | 2026-07-01 | A | 446,102 | 0 | 0 | Common | Form 4 ↗ |
| Daniel McCarthy | PRESIDENT | 2026-08-26 | D | 65,892 | 5 | 329,460 | Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Seth Blackley | PSU | 2025-03-03 | 352,538 | 705,076 | — | 1,762,690 | $9,856,962 |
| Jonathan Weinberg | PSU | 2025-03-03 | 37,772 | 75,543 | — | 75,543 | 1,056,091 |
| Jonathan Weinberg | RSU | 2025-03-03 | — | — | 65,470 | — | 574,172 |
| Emily Rafferty | RSU | 2025-03-03 | — | — | 72,937 | — | 639,657 |
| Emily Rafferty | PSU | 2025-03-03 | 36,469 | 72,938 | — | 182,345 | 1,019,673 |
| Daniel McCarthy | PSU | 2025-03-03 | 235,026 | 470,051 | — | 1,175,128 | 6,571,313 |
| John Johnson | PSU | 2025-03-03 | 133,670 | 267,339 | — | 668,348 | 3,737,399 |
| Jonathan Weinberg | RSU | 2025-07-01 | — | — | 23,394 | — | 272,072 |
| Daniel McCarthy | RSU | 2025-03-03 | — | — | 156,683 | — | 1,374,110 |
| John Johnson | RSU | 2025-03-03 | — | — | 89,113 | — | 781,521 |
| Daniel McCarthy | RSU | 2025-07-01 | — | — | 44,767 | — | 520,640 |
| John Johnson | RSU | 2025-07-01 | — | — | 25,461 | — | 296,111 |
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Seth Blackley | $0 | $9,856,962 | $0 | 100.0% |
| Jonathan Weinberg | 846,244 | 1,056,091 | 0 | 55.5% |
| Emily Rafferty | 639,657 | 1,019,673 | 0 | 61.5% |
| Daniel McCarthy | 1,894,750 | 6,571,313 | 0 | 77.6% |
| John Johnson | 1,077,632 | 3,737,399 | 0 | 77.6% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Seth Blackley | RSU | 189,854 | — | $759,417 |
| Seth Blackley | RSU | 67,150 | — | 268,600 |
| Jonathan Weinberg | RSU | 23,394 | — | 93,576 |
| Emily Rafferty | RSU | 72,937 | — | 291,748 |
| Jonathan Weinberg | RSU | 65,470 | — | 261,880 |
| Jonathan Weinberg | RSU | 75,543 | — | 302,172 |
| Emily Rafferty | RSU | 72,938 | — | 291,752 |
| John Johnson | RSU | 267,339 | — | 1,069,356 |
| Emily Rafferty | RSU | 5,775 | — | 23,100 |
| Seth Blackley | RSU | 705,076 | — | 2,820,304 |
| Daniel McCarthy | RSU | 470,051 | — | 1,880,204 |
| Seth Blackley | RSU | 235,025 | — | 940,100 |
| Daniel McCarthy | RSU | 156,683 | — | 626,732 |
| Daniel McCarthy | RSU | 126,569 | — | 506,276 |
| John Johnson | RSU | 89,113 | — | 356,452 |
| John Johnson | RSU | 79,105 | — | 316,422 |
| Daniel McCarthy | RSU | 44,767 | — | 179,068 |
| John Johnson | RSU | 25,461 | — | 101,844 |
| Emily Rafferty | RSU | 23,731 | — | 94,926 |
| Seth Blackley | RSU | 19,471 | — | 77,884 |
| Seth Blackley | RSU | 19,203 | — | 76,812 |
| Jonathan Weinberg | RSU | 15,821 | — | 63,284 |
| Jonathan Weinberg | RSU | 14,402 | — | 57,608 |
| Daniel McCarthy | RSU | 12,802 | — | 51,208 |
| Daniel McCarthy | RSU | 9,094 | — | 36,376 |
| John Johnson | RSU | 8,001 | — | 32,004 |
| Emily Rafferty | RSU | 7,201 | — | 28,804 |
| John Johnson | RSU | 6,736 | — | 26,944 |
| Jonathan Weinberg | RSU | 4,210 | — | 16,840 |
The Company's executive compensation programs strongly align realized compensation outcomes with the Company's stock price performance.
| CEO STI target (% of salary) | 100% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Exequity |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | true |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-06-04 | 58,369,473 | 7,922,802 | 84,119 | 88.05% | Passed |
| 2025 | 2025-06-05 | 77,588,031 | 10,172,695 | 103,596 | 88.41% | Passed |
| 2024 | 2024-06-06 | 97,716,171 | 5,954,639 | 26,096 | 94.26% | Passed |
| 2023 | 2023-06-08 | 98,899,814 | 1,875,305 | 51,305 | 98.14% | Passed |
| 2022 | 2022-06-09 | 77,483,402 | 2,838,763 | 49,641 | 96.47% | Passed |
| 2021 | 2021-06-10 | 74,996,027 | 273,423 | 77,852 | 99.64% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2026 | 2026-06-04 | 88.05%a |
| 2025 | 2025-06-05 | 88.41%b |
| 2024 | 2024-06-06 | 94.26%c |
a. Approved under the standard stated in the filing — “Proxy Statement 2026 75 Table of Contents Questions and Answers About the Annual Meeting What vote is required to approve each proposal? Proposal Stockholder Vote Required for Approval Effect of Abstentions Effect of Broker Non-Votes (1) 1 Election of Directors Majority of votes cast No effect No effect 2 Ratification of the selection of Deloitte & Touche LLP as our independent public accounting firm Majority of votes cast No effect There will be no broker non-votes 3 Advisory vote to approve executive compensation (2) Majority of votes cast No effect No effect 4 Approval of the Amendment to the Amended and Restated 2015 Omnibus Incentive Compensation Plan Majority of votes cast No effect No effect (1) A "broker non-vote" occurs when a broker holding shares for a street name holder submits a valid proxy but does not vote on a particular proposal because the broker has not received voting instructions from the stockholder for whom it is holding shares and does not have discretionary authority to vote on the matter.”.
b. Approved under the standard stated in the filing — “Proxy Statement 2025 73 Table of Contents Questions and Answers About the Annual Meeting What vote is required to approve each proposal? Proposal Stockholder Vote Required for Approval Effect of Abstentions Effect of Broker Non-Votes (1) 1 Election of Directors Majority of votes cast No effect No effect 2 Ratification of the selection of Deloitte & Touche LLP as our independent public accounting firm Majority of votes cast No effect There will be no broker non-votes 3 Advisory vote to approve executive compensation (2) Majority of votes cast No effect No effect 4 Approval of the Amendment to the Amended and Restated 2015 Omnibus Incentive Compensation Plan Majority of votes cast No effect No effect (1) A "broker non-vote" occurs when a broker holding shares for a street name holder submits a valid proxy but does not vote on a particular proposal because the broker has not received voting instructions from the stockholder for whom it is holding shares and does not have discretionary authority to vote on the matter.”.
c. Approved under the standard stated in the filing — “Abstentions will have no effect on this proposal.”.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Ratio (CEO : median employee) | 192.6 : 1 |
|---|---|
| CEO total compensation | $14,257,351 |
| Median employee compensation | $74,011 |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Richard JelinekIndependent · Board Chair · Compensation · Nominating and Governance (Chair) · Strategy | $245,000 | $180,000 | $0 | $0 | $0 | $425,000 |
| Brendan SpringstubbIndependent · Audit · Compensation · Strategy · Newly elected | 133,417 | 240,000 | 0 | 0 | 0 | 373,417 |
| Kim KeckIndependent · Audit (Chair) · Nominating and Governance | 112,500 | 180,000 | 0 | 0 | 0 | 292,500 |
| Craig BarbaroshIndependent · Compliance and Regulatory Affairs · Strategy (Chair) | 102,500 | 180,000 | 0 | 0 | 0 | 282,500 |
| Toyin Ajayi, MDIndependent · Compensation (Chair) · Nominating/Governance | 102,500 | 180,000 | 0 | 0 | 0 | 282,500 |
| Cheryl ScottIndependent · Departed during FY | 102,500 | 180,000 | 0 | 0 | 0 | 282,500 |
| Peter GruaIndependent · Compensation (Chair) | 100,000 | 180,000 | 0 | 0 | 0 | 280,000 |
| Russell GlassIndependent · Nominating and Governance · Compliance and Regulatory Affairs | 95,000 | 180,000 | 0 | 0 | 0 | 275,000 |
| Shawn GuertinIndependent · Audit | 90,000 | 180,000 | 0 | 0 | 0 | 270,000 |
| M. Bridget Duffy, MDIndependent · Departed during FY | 0 | 0 | 0 | 0 | 0 | 0 |
| Seth BlackleyEmployee director | 0 | 0 | 0 | — | 0 | 0 |
| Diane HolderIndependent · Not standing for re-election | 0 | 0 | 0 | 0 | 0 | 0 |
| Jill SmithIndependent · Partial-year service · Newly elected | 0 | 0 | 0 | 0 | 0 | 0 |
| Annual cash retainer | $75,000 |
|---|---|
| Annual equity retainer | $160,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 25,000 / 20,000 / 15,000 |
| Stock ownership guideline | 5 times annual cash retainer |
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $1,083,417 |
| Equity awards (grant-date value) | $1,680,000 |
| All other compensation | $0 |
| Total cost of the board | $2,763,417 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
Of the companies Evolent Health names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including Evolent Health.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Manhattan Associates, Inc. | 2025 | Eric Clark | $710,000 | $13,000,328 | $0 | $835,375 | $16,697,528 |
| 2 | Astrana Health, Inc. | 2025 | Brandon Sim | 850,000 | 11,999,980 | 0 | 2,059,125 | 14,930,231 |
| 3 | Evolent Health | 2025 | Seth Blackley | 867,068 | 12,699,086 | 0 | 0 | 14,240,154 |
| 4 | R1 RCM Inc. | 2023 | Lee Rivas | 900,000 | 12,240,021 | 0 | 1,015,200 | 14,159,376 |
| 5 | HealthEquity, Inc. | 2026 | Scott Cutler | 775,000 | 12,038,563 | 0 | 767,250 | 13,582,105 |
| 6 | RadNet, Inc. | 2025 | Howard Berger | 3,000,000 | 8,999,966 | 0 | 0 | 12,087,934 |
| 7 | Premier, Inc. | 2024 | Michael Alkire | 1,095,876 | 8,500,039 | 0 | 1,800,150 | 11,806,381 |
| 8 | Teladoc Health, Inc. | 2025 | Charles Divita, III | 800,000 | 9,699,996 | 0 | 584,000 | 11,202,996 |
| 9 | AMN Healthcare Services, Inc. | 2025 | Cary Grace | 1,060,000 | 8,363,117 | 0 | 1,146,125 | 10,669,780 |
| 10 | Option Care Health, Inc. | 2025 | John Rademacher | 1,000,000 | 6,500,050 | 0 | 1,665,000 | 9,266,330 |
| 11 | Omnicell, Inc. | 2025 | Randall Lipps | 846,891 | 5,219,576 | 0 | 1,411,485 | 7,531,852 |
| 12 | Surgery Partners, Inc. | 2025 | J. Eric Evans | 1,050,000 | 5,000,000 | 0 | 0 | 6,083,862 |
| 13 | agilon Health, Inc. | 2025 | Jeffrey Schwaneke | 625,000 | 2,950,003 | 1,750,000 | 271,875 | 5,610,878 |
| 14 | Pediatrix Medical Group, Inc. | 2025 | James Swift | 54,167 | 730,720 | 0 | 68,981 | 2,775,881 |
| 15 | CorVel Corporation | 2026 | Michael Combs | 679,327 | 0 | 101,716 | 498,809 | 1,285,043 |
| 16 | Oscar Health, Inc. | 2025 | Mark Bertolini | 619,178 | 0 | 0 | 169,036 | 1,149,308 |
| 17 | Veeva Systems, Inc. | 2026 | Peter Gassner | 470,833 | 0 | 0 | 0 | 470,833 |
| — | Amedisys, Inc. | — | — | — | — | — | — | not in coverage universe |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| Evolent Health | 75% | PSU 70 · RSU 30 | No | Exequity |
| agilon Health, Inc. | 58% | not disclosed | No | Semler Brossy |
| Amedisys, Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| AMN Healthcare Services, Inc. | 87% | not disclosed | Yes — Relative TSR | FW Cook |
| Astrana Health, Inc. | 193.8% | PSU 67 · RSU 33 | No | Pearl Meyer |
| CorVel Corporation | CEO: 75%, EVP Risk: 61%, CIO: 49%, VP Accounting: 28%% | not disclosed | No | not disclosed |
| HealthEquity, Inc. | 99% | PSU 60 · RSU 40 | Yes | Semler Brossy |
| Manhattan Associates, Inc. | 118% | RSU 50 · PSU 50 | No | Willis Towers Watson |
| Omnicell, Inc. | 133.3% | RSU 50 · PSU 50 | No | Exequity |
| Option Care Health, Inc. | 111% | PSU 60 · RSU 40 | No | Pearl Meyer |
| Oscar Health, Inc. | 91.0% | PSU 50 · RSU 50 | Yes — Relative TSR | FW Cook |
| Pediatrix Medical Group, Inc. | 180% | PSU 50 · RSU 50 | No | Semler Brossy Consulting Group |
| Premier, Inc. | 109.1% | PSU 60 · RSU 40 | No | Mercer |
| R1 RCM Inc. | 94% | PSU 75 · RSU 25 | No | SullivanCotter |
| RadNet, Inc. | not disclosed | RSU 100 | No | Pearl Meyer |
| Surgery Partners, Inc. | not disclosed | PSU 60 · Restricted Stock 40 | No | Frederic W. Cook & Co., Inc. (FW Cook) |
| Teladoc Health, Inc. | 73% | RSU 50 · PSU 50 | No | Aon |
| Veeva Systems, Inc. | not disclosed | Options 100 | not disclosed | Compensia |
Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Seth Blackley | DEF 14A | 2026-04-24 | 0001193125-26-177267 | Section “Summary Compensation Table” · page 48. As printed: 14,240,154. Filing ↗machine: r3 · c20 · span 908544–908555 |
| 2 | Section 01, Daniel McCarthy | DEF 14A | 2026-04-24 | 0001193125-26-177267 | Section “Summary Compensation Table” · page 48. As printed: 9,623,279. Filing ↗machine: r11 · c21 · span 926946–926955 |
| 3 | Section 01, John Johnson | DEF 14A | 2026-04-24 | 0001193125-26-177267 | Section “Summary Compensation Table” · page 48. As printed: 5,370,671. Filing ↗machine: r7 · c21 · span 917785–917794 |
| 4 | Section 01, Jonathan Weinberg | DEF 14A | 2026-04-24 | 0001193125-26-177267 | Section “Summary Compensation Table” · page 48. As printed: 2,639,664. Filing ↗machine: r19 · c21 · span 945452–945461 |
| 5 | Section 01, Emily Rafferty | DEF 14A | 2026-04-24 | 0001193125-26-177267 | Section “Summary Compensation Table” · page 48. As printed: 2,404,625. Filing ↗machine: r15 · c20 · span 936239–936248 |
| 6 | Section 03, Seth Blackley PSU | DEF 14A | 2026-04-24 | 0001193125-26-177267 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t212 · r4 · c34 · span 971381–971390 |
| 7 | Section 03, Jonathan Weinberg PSU | DEF 14A | 2026-04-24 | 0001193125-26-177267 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: span 1014301–1014310 |
| 8 | Section 03, Jonathan Weinberg RSU | DEF 14A | 2026-04-24 | 0001193125-26-177267 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: span 1018412–1018419 |
| 9 | Section 03, Emily Rafferty RSU | DEF 14A | 2026-04-24 | 0001193125-26-177267 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: span 1010086–1010093 |
| 10 | Section 03, Emily Rafferty PSU | DEF 14A | 2026-04-24 | 0001193125-26-177267 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: span 1006025–1006034 |
| 11 | Section 03, Daniel McCarthy PSU | DEF 14A | 2026-04-24 | 0001193125-26-177267 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: span 993639–993648 |
| 12 | Section 03, John Johnson PSU | DEF 14A | 2026-04-24 | 0001193125-26-177267 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: span 982567–982576 |
| 13 | Section 03, Jonathan Weinberg RSU | DEF 14A | 2026-04-24 | 0001193125-26-177267 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: span 1022523–1022530 |
| 14 | Section 03, Daniel McCarthy RSU | DEF 14A | 2026-04-24 | 0001193125-26-177267 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: span 997751–997760 |
| 15 | Section 03, John Johnson RSU | DEF 14A | 2026-04-24 | 0001193125-26-177267 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: span 985995–986002 |
| 16 | Section 03, Daniel McCarthy RSU | DEF 14A | 2026-04-24 | 0001193125-26-177267 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: span 1001862–1001869 |
| 17 | Section 03, John Johnson RSU | DEF 14A | 2026-04-24 | 0001193125-26-177267 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: span 989421–989428 |
| 18 | Section 07, pay ratio | DEF 14A | 2026-04-24 | 0001193125-26-177267 | Section “CEO Pay Ratio”. As printed: 192.6 : 1. Filing ↗machine: span 1378512–1378517 |
| 19 | Section 08, Richard Jelinek | DEF 14A | 2026-04-24 | 0001193125-26-177267 | Section “Director Compensation”. As printed: 425,000. Filing ↗machine: span 300593–300653 |
| 20 | Section 08, Brendan Springstubb | DEF 14A | 2026-04-24 | 0001193125-26-177267 | Section “Director Compensation”. As printed: 373,417. Filing ↗machine: span 317556–317616 |
| 21 | Section 08, Kim Keck | DEF 14A | 2026-04-24 | 0001193125-26-177267 | Section “Director Compensation”. As printed: 292,500. Filing ↗machine: span 304777–304837 |
| 22 | Section 08, Craig Barbarosh | DEF 14A | 2026-04-24 | 0001193125-26-177267 | Section “Director Compensation”. As printed: 282,500. Filing ↗machine: span 275229–275289 |
| 23 | Section 08, Toyin Ajayi, MD | DEF 14A | 2026-04-24 | 0001193125-26-177267 | Section “Director Compensation”. As printed: 282,500. Filing ↗machine: span 271088–271148 |
| 24 | Section 08, Cheryl Scott | DEF 14A | 2026-04-24 | 0001193125-26-177267 | Section “Director Compensation”. As printed: 282,500. Filing ↗machine: span 308971–309031 |
| 25 | Section 08, Peter Grua | DEF 14A | 2026-04-24 | 0001193125-26-177267 | Section “Director Compensation”. As printed: 280,000. Filing ↗machine: span 287900–287960 |
| 26 | Section 08, Russell Glass | DEF 14A | 2026-04-24 | 0001193125-26-177267 | Section “Director Compensation”. As printed: 275,000. Filing ↗machine: span 283714–283774 |
| 27 | Section 08, Shawn Guertin | DEF 14A | 2026-04-24 | 0001193125-26-177267 | Section “Director Compensation”. As printed: 270,000. Filing ↗machine: span 292038–292098 |
| 28 | Section 08, M. Bridget Duffy, MD | DEF 14A | 2026-04-24 | 0001193125-26-177267 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 29 | Section 08, Seth Blackley | DEF 14A | 2026-04-24 | 0001193125-26-177267 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 30 | Section 08, Diane Holder | DEF 14A | 2026-04-24 | 0001193125-26-177267 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 31 | Section 08, Jill Smith | DEF 14A | 2026-04-24 | 0001193125-26-177267 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 32 | Section 02, Craig Barbarosh 2026-06-04 | Form 4 | 2026-06-08 | 0001628908-26-000039 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 33 | Section 02, Brendan Springstubb 2026-06-04 | Form 4 | 2026-06-08 | 0001628908-26-000041 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 34 | Section 02, Jill Smith 2026-06-04 | Form 4 | 2026-06-08 | 0001628908-26-000043 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 35 | Section 02, Kim Keck 2026-06-04 | Form 4 | 2026-06-08 | 0001628908-26-000046 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 36 | Section 02, Richard Jelinek 2026-06-04 | Form 4 | 2026-06-08 | 0001628908-26-000049 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 37 | Section 02, Shawn Guertin 2026-06-04 | Form 4 | 2026-06-08 | 0001628908-26-000051 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 38 | Section 02, Peter Grua 2026-06-04 | Form 4 | 2026-06-08 | 0001628908-26-000053 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 39 | Section 02, Russell Glass 2026-06-04 | Form 4 | 2026-06-08 | 0001628908-26-000055 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 40 | Section 02, Toyin Ajayi, MD 2026-06-04 | Form 4 | 2026-06-08 | 0001628908-26-000057 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 41 | Section 02, Aammaad Shams 2026-07-01 | Form 4 | 2026-07-06 | 0001628908-26-000066 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 42 | Section 02, Daniel McCarthy 2026-07-01 | Form 4 | 2026-07-06 | 0001628908-26-000068 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 43 | Section 02, Jonathan Weinberg 2026-07-01 | Form 4 | 2026-07-06 | 0001642833-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 44 | Section 02, Seth Blackley 2026-07-01 | Form 4 | 2026-07-06 | 0001628908-26-000070 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 45 | Section 02, Daniel McCarthy 2026-07-01 | Form 4 | 2026-07-06 | 0001628908-26-000068 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 46 | Section 02, Jonathan Weinberg 2026-07-01 | Form 4 | 2026-07-06 | 0001642833-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 47 | Section 02, Seth Blackley 2026-07-01 | Form 4 | 2026-07-06 | 0001628908-26-000070 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 48 | Section 02, Daniel McCarthy 2026-08-26 | Form 4 | 2026-08-28 | 0001628908-26-000088 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 49 | Section 06, 2026 vote | Form 8-K | 2026-06-04 | 0001628908-26-000037 | Item 5.07 · say-on-pay result. As reported: 88.05% (votes for as printed: 58,369,473). Filing ↗ |
| 50 | Section 06, 2025 vote | Form 8-K | 2025-06-05 | 0001628908-25-000072 | Item 5.07 · say-on-pay result. As reported: 88.41% (votes for as printed: 77,588,031). Filing ↗ |
| 51 | Section 06, 2024 vote | Form 8-K | 2024-06-11 | 0001628908-24-000080 | Item 5.07 · say-on-pay result. As reported: 94.26% (votes for as printed: 97,716,171). Filing ↗ |
| 52 | Section 01 trend, Δ column (computed) | Computed | — | — | Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1) |
| 53 | Section 03b vehicle mix (computed) | Computed | — | — | RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio |
| 54 | Section 09b board cost (computed) | Computed | — | — | Cash 1,083,417 + equity 1,680,000 + all other 0 = 2,763,417, summed across the director compensation table rows.machine: formula: Σ = 2,763,417 |
| 55 | Manhattan Associates, Inc., Section 10b CEO total | DEF 14A | 2026-04-02 | 0001193125-26-140024 | CEO total compensation as printed in Manhattan Associates, Inc.'s own proxy. As printed: 16,697,528. Filing ↗machine: r7 · c24 · span 1260363–1260373 |
| 56 | Astrana Health, Inc., Section 10b CEO total | DEF 14A | 2026-04-17 | 0001104659-26-044536 | CEO total compensation as printed in Astrana Health, Inc.'s own proxy. As printed: 14,930,231. Filing ↗machine: span 525189–525199 |
| 57 | Evolent Health (subject), Section 10b CEO total | DEF 14A | 2026-04-24 | 0001193125-26-177267 | CEO total compensation as printed in Evolent Health's own proxy. As printed: 14,240,154. Filing ↗machine: r3 · c20 · span 908544–908555 |
| 58 | R1 RCM Inc., Section 10b CEO total | DEF 14A | 2024-04-12 | 0001628280-24-015923 | CEO total compensation as printed in R1 RCM Inc.'s own proxy. As printed: 14,159,376. Filing ↗machine: span 758069–758079 |
| 59 | HealthEquity, Inc., Section 10b CEO total | DEF 14A | 2026-05-13 | 0001428336-26-000022 | CEO total compensation as printed in HealthEquity, Inc.'s own proxy. As printed: 13,582,105. Filing ↗machine: r3 · c21 · span 892475–892485 |
| 60 | RadNet, Inc., Section 10b CEO total | DEF 14A | 2026-04-20 | 0001683168-26-003086 | CEO total compensation as printed in RadNet, Inc.'s own proxy. As printed: 12,087,934. Filing ↗machine: t93 · r1 · c26 · span 428610–428620 |
| 61 | Premier, Inc., Section 10b CEO total | DEF 14A | 2024-10-21 | 0001193125-24-240399 | CEO total compensation as printed in Premier, Inc.'s own proxy. As printed: 11,806,381. Filing ↗machine: span 1173351–1173361 |
| 62 | Teladoc Health, Inc., Section 10b CEO total | DEF 14A | 2026-04-07 | 0001477449-26-000020 | CEO total compensation as printed in Teladoc Health, Inc.'s own proxy. As printed: 11,202,996. Filing ↗machine: t167 · r2 · c16 · span 1057476–1057486 |
| 63 | AMN Healthcare Services, Inc., Section 10b CEO total | DEF 14A | 2026-03-18 | 0001104659-26-029908 | CEO total compensation as printed in AMN Healthcare Services, Inc.'s own proxy. As printed: 10,669,780. Filing ↗machine: t94 · r1 · c42 · span 1287064–1287074 |
| 64 | Option Care Health, Inc., Section 10b CEO total | DEF 14A | 2026-04-08 | 0001140361-26-013825 | CEO total compensation as printed in Option Care Health, Inc.'s own proxy. As printed: 9,266,330. Filing ↗machine: r2 · c25 · span 1114074–1114083 |
| 65 | Omnicell, Inc., Section 10b CEO total | DEF 14A | 2026-04-13 | 0001104659-26-042631 | CEO total compensation as printed in Omnicell, Inc.'s own proxy. As printed: 7,531,852. Filing ↗machine: r1 · c47 · span 668949–668958 |
| 66 | Surgery Partners, Inc., Section 10b CEO total | DEF 14A | 2026-04-23 | 0001638833-26-000039 | CEO total compensation as printed in Surgery Partners, Inc.'s own proxy. As printed: 6,083,862. Filing ↗machine: r2 · c24 · span 365862–365872 |
| 67 | agilon Health, Inc., Section 10b CEO total | DEF 14A | 2026-04-22 | 0001628280-26-026544 | CEO total compensation as printed in agilon Health, Inc.'s own proxy. As printed: 5,610,878. Filing ↗machine: r5 · c9 · span 1591317–1591326 |
| 68 | Pediatrix Medical Group, Inc., Section 10b CEO total | DEF 14A | 2026-03-27 | 0001193125-26-127299 | CEO total compensation as printed in Pediatrix Medical Group, Inc.'s own proxy. As printed: 2,775,881. Filing ↗machine: r22 · c24 · span 1960691–1960700 |
| 69 | CorVel Corporation, Section 10b CEO total | DEF 14A | 2026-06-26 | 0001193125-26-285509 | CEO total compensation as printed in CorVel Corporation's own proxy. As printed: 1,285,043. Filing ↗machine: span 348386–348395 |
| 70 | Oscar Health, Inc., Section 10b CEO total | DEF 14A | 2026-04-22 | 0001140361-26-016119 | CEO total compensation as printed in Oscar Health, Inc.'s own proxy. As printed: 1,149,308. Filing ↗machine: t173 · r2 · c25 · span 1052592–1052601 |
| 71 | Veeva Systems, Inc., Section 10b CEO total | DEF 14A | 2026-05-04 | 0001140361-26-018796 | CEO total compensation as printed in Veeva Systems, Inc.'s own proxy. As printed: 470,833. Filing ↗machine: t223 · r2 · c7 · span 807038–807045 |
| 72 | Section 10a, Option Care Health, Inc. reciprocity | DEF 14A | — | 0001140361-26-013825 | Option Care Health, Inc.'s most recent proxy was read; its disclosed peer group does not include Evolent Health. Filing ↗ |
| 73 | Section 10a, Oscar Health, Inc. reciprocity | DEF 14A | — | 0001140361-26-016119 | Oscar Health, Inc.'s most recent proxy was read; its disclosed peer group does not include Evolent Health. Filing ↗ |
| 74 | Section 10a, RadNet, Inc. reciprocity | DEF 14A | — | 0001683168-26-003086 | RadNet, Inc.'s most recent proxy was read; its disclosed peer group does not include Evolent Health. Filing ↗ |
| 75 | Section 10a, HealthEquity, Inc. reciprocity | DEF 14A | — | 0001428336-26-000022 | HealthEquity, Inc. names Evolent Health in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 76 | Section 10a, R1 RCM Inc. reciprocity | DEF 14A | — | 0001628280-24-015923 | R1 RCM Inc.'s most recent proxy was read; its disclosed peer group does not include Evolent Health. Filing ↗ |
| 77 | Section 10a, agilon Health, Inc. reciprocity | DEF 14A | — | 0001628280-26-026544 | agilon Health, Inc. names Evolent Health in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 78 | Section 10a, AMN Healthcare Services, Inc. reciprocity | DEF 14A | — | 0001104659-26-029908 | AMN Healthcare Services, Inc. names Evolent Health in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 79 | Section 10a, Premier, Inc. reciprocity | DEF 14A | — | 0001193125-24-240399 | Premier, Inc. names Evolent Health in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 80 | Section 10a, CorVel Corporation reciprocity | DEF 14A | — | 0001193125-24-165642 | CorVel Corporation's most recent proxy was read; its disclosed peer group does not include Evolent Health. Filing ↗ |
| 81 | Section 10a, Surgery Partners, Inc. reciprocity | DEF 14A | — | 0001638833-26-000039 | Surgery Partners, Inc.'s most recent proxy was read; its disclosed peer group does not include Evolent Health. Filing ↗ |
| 82 | Section 10a, Manhattan Associates, Inc. reciprocity | DEF 14A | — | 0001193125-26-140024 | Manhattan Associates, Inc.'s most recent proxy was read; its disclosed peer group does not include Evolent Health. Filing ↗ |
| 83 | Section 10a, Teladoc Health, Inc. reciprocity | DEF 14A | — | 0001477449-26-000020 | Teladoc Health, Inc. names Evolent Health in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 84 | Section 10a, Omnicell, Inc. reciprocity | DEF 14A | — | 0001104659-26-042631 | Omnicell, Inc. names Evolent Health in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 85 | Section 10a, Veeva Systems, Inc. reciprocity | DEF 14A | — | 0001140361-26-018796 | Veeva Systems, Inc.'s most recent proxy was read; its disclosed peer group does not include Evolent Health. Filing ↗ |
The Pay Desk — the free weekly executive pay briefing, one company at a time, every number traceable to a public filing.
You'll confirm on The Pay Desk's sign-up page.